These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22814208)

  • 1. Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer's disease.
    Schipke CG; Peters O; Heuser I; Grimmer T; Sabbagh MN; Sabri O; Hock C; Kunz M; Kuhlmann J; Reininger C; Blankenburg M
    Dement Geriatr Cogn Disord; 2012; 33(6):416-22. PubMed ID: 22814208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans.
    Rullmann M; Dukart J; Hoffmann KT; Luthardt J; Tiepolt S; Patt M; Gertz HJ; Schroeter ML; Seibyl J; Schulz-Schaeffer WJ; Sabri O; Barthel H
    J Nucl Med; 2016 Feb; 57(2):198-203. PubMed ID: 26541776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls.
    Barthel H; Luthardt J; Becker G; Patt M; Hammerstein E; Hartwig K; Eggers B; Sattler B; Schildan A; Hesse S; Meyer PM; Wolf H; Zimmermann T; Reischl J; Rohde B; Gertz HJ; Reininger C; Sabri O
    Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1702-14. PubMed ID: 21547601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study.
    Sabri O; Sabbagh MN; Seibyl J; Barthel H; Akatsu H; Ouchi Y; Senda K; Murayama S; Ishii K; Takao M; Beach TG; Rowe CC; Leverenz JB; Ghetti B; Ironside JW; Catafau AM; Stephens AW; Mueller A; Koglin N; Hoffmann A; Roth K; Reininger C; Schulz-Schaeffer WJ;
    Alzheimers Dement; 2015 Aug; 11(8):964-74. PubMed ID: 25824567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Florbetaben to trace amyloid-β in the Alzheimer brain by means of PET.
    Barthel H; Sabri O
    J Alzheimers Dis; 2011; 26 Suppl 3():117-21. PubMed ID: 21971456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
    Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
    Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease.
    Sabbagh MN; Schäuble B; Anand K; Richards D; Murayama S; Akatsu H; Takao M; Rowe CC; Masters CL; Barthel H; Gertz HJ; Peters O; Rasgon N; Jovalekic A; Sabri O; Schulz-Schaeffer WJ; Seibyl J
    J Alzheimers Dis; 2017; 56(2):441-446. PubMed ID: 27983552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of amyloid PET/CT with
    Ferrari C; Caputo P; Pisani AR; Nappi AG; Branca A; Lavelli V; Rubini G
    Hell J Nucl Med; 2019; 22 Suppl 2():142-152. PubMed ID: 31802055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amyloid positron-emission-tomography with [
    Schönecker S; Prix C; Raiser T; Ackl N; Wlasich E; Stenglein-Krapf G; Mille E; Brendel M; Sabri O; Patt M; Barthel H; Bartenstein P; Levin J; Rominger A; Danek A
    Nervenarzt; 2017 Feb; 88(2):156-161. PubMed ID: 27913818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Incremental Diagnostic Value of [18F]Florbetaben PET and the Pivotal Role of the Neuropsychological Assessment in Clinical Practice.
    Spallazzi M; Barocco F; Michelini G; Morelli N; Scarlattei M; Baldari G; Ruffini L; Caffarra P
    J Alzheimers Dis; 2019; 67(4):1235-1244. PubMed ID: 30689568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of scan duration on the accuracy of β-amyloid PET with florbetaben in patients with Alzheimer's disease and healthy volunteers.
    Tiepolt S; Barthel H; Butzke D; Hesse S; Patt M; Gertz HJ; Reininger C; Sabri O
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):238-44. PubMed ID: 23104671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.
    Barthel H; Gertz HJ; Dresel S; Peters O; Bartenstein P; Buerger K; Hiemeyer F; Wittemer-Rump SM; Seibyl J; Reininger C; Sabri O;
    Lancet Neurol; 2011 May; 10(5):424-35. PubMed ID: 21481640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET quantification of 18F-florbetaben binding to β-amyloid deposits in human brains.
    Becker GA; Ichise M; Barthel H; Luthardt J; Patt M; Seese A; Schultze-Mosgau M; Rohde B; Gertz HJ; Reininger C; Sabri O
    J Nucl Med; 2013 May; 54(5):723-31. PubMed ID: 23471310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of florbetaben PET imaging and the amyloid peptide Aß42 in cerebrospinal fluid.
    Schipke CG; Koglin N; Bullich S; Joachim LK; Haas B; Seibyl J; Barthel H; Sabri O; Peters O
    Psychiatry Res Neuroimaging; 2017 Jul; 265():98-101. PubMed ID: 28024844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of 18F Florbetaben in Diagnosis of Alzheimer's Disease and Other Types of Dementia.
    Chiaravalloti A; Danieli R; Lacanfora A; Palumbo B; Caltagirone C; Schillaci O
    Curr Alzheimer Res; 2017; 14(2):154-160. PubMed ID: 27334940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project.
    de Wilde A; van der Flier WM; Pelkmans W; Bouwman F; Verwer J; Groot C; van Buchem MM; Zwan M; Ossenkoppele R; Yaqub M; Kunneman M; Smets EMA; Barkhof F; Lammertsma AA; Stephens A; van Lier E; Biessels GJ; van Berckel BN; Scheltens P
    JAMA Neurol; 2018 Sep; 75(9):1062-1070. PubMed ID: 29889941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET.
    Rominger A; Brendel M; Burgold S; Keppler K; Baumann K; Xiong G; Mille E; Gildehaus FJ; Carlsen J; Schlichtiger J; Niedermoser S; Wängler B; Cumming P; Steiner H; Herms J; Haass C; Bartenstein P
    J Nucl Med; 2013 Jul; 54(7):1127-34. PubMed ID: 23729696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias.
    Villemagne VL; Ong K; Mulligan RS; Holl G; Pejoska S; Jones G; O'Keefe G; Ackerman U; Tochon-Danguy H; Chan JG; Reininger CB; Fels L; Putz B; Rohde B; Masters CL; Rowe CC
    J Nucl Med; 2011 Aug; 52(8):1210-7. PubMed ID: 21764791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of
    Doré V; Bullich S; Rowe CC; Bourgeat P; Konate S; Sabri O; Stephens AW; Barthel H; Fripp J; Masters CL; Dinkelborg L; Salvado O; Villemagne VL; De Santi S
    Alzheimers Dement; 2019 Jun; 15(6):807-816. PubMed ID: 31101517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of in vivo
    Bucerius J; Barthel H; Tiepolt S; Werner P; Sluimer JC; Wildberger JE; Patt M; Hesse S; Gertz HJ; Biessen EAL; Mottaghy FM; Sabri O
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1119-1128. PubMed ID: 28321471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.